Academic Pharmaceuticals

Lake Bluff, IL

UEI
ZC8ZATDAATL9
CAGE
4BPH3
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
21 N Skokie Hwy Ste G3, Lake Bluff, IL 60044, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Soestolol: a potentially short acting type III anti-arrhythmic R43HL147659 National Heart Lung and Blood Institute (NIH) $153,260
Developing a parenteral formulation of metolazone R43DK121641 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $158,460
A safer cardiac, abuse deterrent formulation of methadone R43HL132651 National Institutes of Health $149,980
Reducing methadone's arrhythmic potential R43HL095160 National Institutes of Health $102,910
Pediatric acceptable formulation of amiodarone R43HL095161 National Institutes of Health $100,188

Quick answers

Is Academic Pharmaceuticals registered in SAM.gov?

Yes. Academic Pharmaceuticals's SAM.gov registration is active through December 15, 2026.

What is Academic Pharmaceuticals's most recent federal award?

Academic Pharmaceuticals's most recent federal grant award is Soestolol: a potentially short acting type III anti-arrhythmic (R43HL147659), from National Heart Lung and Blood Institute (NIH), on July 15, 2019.

On GovTribe

See Academic Pharmaceuticals's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login